BioSenic S.A. (BIOS.BR)

EUR 0.01

(-5.71%)

Annual Income Statements

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 543 Thousand 266 Thousand 1 Million 1 Million - 1 Million
Cost of Revenue - 60 Thousand 13 Thousand - 228 Thousand -
Gross Profit 543 Thousand 206 Thousand 987 Thousand 1 Million -228 Thousand 1 Million
Operating Expenses 7.58 Million 2.31 Million 13.02 Million 16.01 Million 11.17 Million 12.46 Million
Selling, General and Administrative Expenses 3.65 Million 619 Thousand 1.76 Million 1.81 Million 1.54 Million 1.72 Million
Research and Development Expenses 3.74 Million 1.03 Million 11.68 Million 15.41 Million 11.18 Million 12.88 Million
Other Expenses 191 Thousand - - - - -
Cost and Expenses 7.58 Million 2.31 Million 13.02 Million 16.01 Million 11.17 Million 12.46 Million
Operating Income -7.04 Million -2.31 Million -12.02 Million -15.01 Million -11.17 Million -11.46 Million
Interest Expense 5.95 Million 278 Thousand 845 Thousand 678 Thousand 398 Thousand 301 Thousand
Income Tax Expense -7000.00 -1.01 Million 89 Thousand 78 Thousand 38 Thousand 131 Thousand
Earnings before Tax -29.02 Million -3.04 Million -12.83 Million -15.75 Million -10.29 Million -14.01 Million
Net Income -28.77 Million -2.04 Million -12.92 Million -11.94 Million -10.46 Million -14.21 Million
Earnings Per Share Basic -0.21 -0.02 -0.61 -1.02 -1.10 -1.87
Earnings Per Share Diluted -0.21 -0.02 -0.61 -1.02 -1.10 -1.87
Weighted Average Shares Outstanding 137.03 Million 120.13 Million 21.31 Million 11.72 Million 9.53 Million 7.61 Million
Weighted Average Shares Outstanding (Diluted) 137.03 Million 120.13 Million 21.31 Million 11.72 Million 9.53 Million 7.61 Million
Gross Margin 1.00 0.77 0.99 1.00 - 1.00
EBIT Margin -12.52 -8.52 -11.80 -14.48 - -13.09
Profit Margin -53.00 -7.67 -12.92 -11.94 - -14.22
EBITDA -6.79 Million -2.25 Million -864 Thousand -14.83 Million -6.69 Million -13.13 Million
Earnings Before Tax Margin -12.97 -8.71 -12.03 -15.02 - -11.47

Income Statement Charts